Related Experiment Video
Updated: Jan 27, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity
Ishita Gupta1, Rasha M Sareyeldin2, Israa Al-Hashimi3
1College of Medicine, Qatar University, Doha P. O. Box:2713, Qatar. ishugupta28@gmail.com.
Abstract:
Breast cancer is the most frequent cause of cancer-related deaths among women worldwide. It is classified into four major molecular subtypes. Triple-negative breast cancers (TNBCs), a subgroup of breast cancer, are defined by the absence of estrogen and progesterone receptors and the lack of HER-2 expression; this subgroup accounts for ~15% of all breast cancers and exhibits the most aggressive metastatic behavior. Currently, very limited targeted therapies exist for the treatment of patients with TNBCs. On the other hand, it is important to highlight that knowledge of the molecular biology of breast cancer has recently changed the decision-making process regarding the course of cancer therapies. Thus, a number of new techniques, such as gene profiling and sequencing, proteomics, and microRNA analysis have been used to explore human breast carcinogenesis and metastasis including TNBC, which consequently could lead to new therapies. Nevertheless, based on evidence thus far, genomics profiles (gene and miRNA) can differ from one geographic location to another as well as in different ethnic groups. This review provides a comprehensive and updated information on the genomics profile alterations associated with TNBC pathogenesis associated with different ethnic backgrounds.
Insights
Triple-negative breast cancer (TNBC) is aggressive, with few treatments. This review explores TNBC genomics across diverse ethnic groups to inform new targeted therapies.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Breast cancer is a leading cause of cancer death in women globally, with distinct molecular subtypes.
- Triple-negative breast cancer (TNBC) lacks hormone receptors and HER-2, representing ~15% of cases and exhibiting aggressive metastasis.
- Limited targeted therapies are available for TNBC, highlighting the need for deeper molecular understanding.
Purpose of the Study:
- To provide a comprehensive review of genomic profile alterations in triple-negative breast cancer (TNBC) pathogenesis.
- To highlight variations in TNBC genomics across different ethnic backgrounds and geographic locations.
- To inform the development of novel targeted therapies for TNBC.
Main Methods:
- Literature review of recent studies on breast cancer genomics.
- Analysis of gene profiling, sequencing, proteomics, and microRNA data related to TNBC.
- Synthesis of information on ethnic and geographic variations in TNBC genomic profiles.
Main Results:
- Genomic profiles, including gene and microRNA alterations, can vary significantly between different ethnic groups and geographic regions.
- Understanding these variations is crucial for developing effective, personalized therapies for TNBC.
- Recent advancements in molecular biology techniques are enhancing the exploration of breast cancer carcinogenesis and metastasis.
Conclusions:
- Genomic heterogeneity in TNBC necessitates tailored therapeutic strategies considering ethnic and geographic factors.
- Further research into the specific genomic alterations in diverse populations will drive the discovery of new TNBC treatments.
- Integrating multi-omics data offers a promising avenue for unraveling TNBC complexity and improving patient outcomes.
Related Concept Videos
MicroRNAs
MicroRNAs
Ethnic Identity within a Larger Culture
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....

